Pantoprazole Sodium DR is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Northwind Pharmaceuticals, Llc. The primary component is Pantoprazole Sodium.
| Product ID | 51655-501_9fe62b0e-e0ec-4b5b-8431-d211b60a85c3 |
| NDC | 51655-501 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pantoprazole Sodium DR |
| Generic Name | Pantoprazole Sodium |
| Dosage Form | Tablet, Delayed Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-07-16 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA077056 |
| Labeler Name | Northwind Pharmaceuticals, LLC |
| Substance Name | PANTOPRAZOLE SODIUM |
| Active Ingredient Strength | 40 mg/1 |
| Pharm Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2014-07-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA077056 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-07-16 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| PANTOPRAZOLE SODIUM | 40 mg/1 |
| SPL SET ID: | 25a1efd6-b6e1-4367-8f74-0f4b8087ae99 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 51655-501 | Pantoprazole Sodium DR | Pantoprazole Sodium DR |
| 61919-806 | PANTOPRAZOLE SODIUM DR | PANTOPRAZOLE SODIUM DR |
| 0093-0011 | Pantoprazole Sodium | Pantoprazole Sodium |
| 0093-0012 | Pantoprazole Sodium | Pantoprazole Sodium |
| 0143-9284 | Pantoprazole Sodium | Pantoprazole Sodium |
| 0008-0841 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-0843 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-0844 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-0923 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-0941 | Protonix | pantoprazole sodium |
| 0008-2001 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-4001 | Protonix | PANTOPRAZOLE SODIUM |